T-Cypher Bio Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
T-Cypher Bio, based in Oxford, England, is a small to mid-sized biotechnology company. It develops therapies derived from T-cell receptors to address immune-mediated diseases. The company aims to deepen understanding of T cell-mediated immunity by profiling the immune synapse at high throughput and high resolution to map intracellular targets and T cell specificity. This work also generates large immune-system data sets that support computational modeling of T cell repertoires. In oncology, the firm validates shared tumour-specific targets and identifies panels of rare, functionally defined T cell clones to advance its drug discovery program. The unique TCRs uncovered through this approach form the foundation of its broader pipeline aimed at solid tumours. The organisation operates with a small to mid-sized team.